866-997-4948(US-Canada Toll Free)

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2013-2022

Published By :

MarketLine

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 205 Pages

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2013-2022

Summary

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the G8 pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- The G8 countries contributed $654.1 billion in 2017 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 5.5% between 2013 and 2017. The G8 countries are expected to reach a value of $851.7 billion in 2022, with a CAGR of 5.4% over the 2017-22 period.
- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $401.0 billion in 2017. This was followed by Germany and Japan, with a value of $71.3 and $68.2 billion, respectively.
- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $552.0 billion in 2016, followed by Germany and Japan with expected values of $90.5 and $70.1 billion, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to buy

- What was the size of the G8 pharmaceuticals market by value in 2017?
- What will be the size of the G8 pharmaceuticals market in 2022?
- What factors are affecting the strength of competition in the G8 pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the G8 pharmaceuticals market?
Table of Contents
Introduction 14
What is this report about? 14
Who is the target reader? 14
How to use this report 14
Definitions 14
Group of Eight (G8) Pharmaceuticals 15
Industry Outlook 15
Pharmaceuticals in Canada 19
Market Overview 19
Market Data 20
Market Segmentation 21
Market outlook 23
Five forces analysis 24
Macroeconomic indicators 33
Pharmaceuticals in France 35
Market Overview 35
Market Data 36
Market Segmentation 37
Market outlook 39
Five forces analysis 40
Macroeconomic indicators 48
Pharmaceuticals in Germany 50
Market Overview 50
Market Data 51
Market Segmentation 52
Market outlook 54
Five forces analysis 55
Macroeconomic indicators 64
Pharmaceuticals in Italy 66
Market Overview 66
Market Data 67
Market Segmentation 68
Market outlook 70
Five forces analysis 71
Macroeconomic indicators 80
Pharmaceuticals in Japan 82
Market Overview 82
Market Data 83
Market Segmentation 84
Market outlook 86
Five forces analysis 87
Macroeconomic indicators 96
Pharmaceuticals in Russia 98
Market Overview 98
Market Data 99
Market Segmentation 100
Market outlook 102
Five forces analysis 103
Macroeconomic indicators 113
Pharmaceuticals in The United Kingdom 115
Market Overview 115
Market Data 116
Market Segmentation 117
Market outlook 119
Five forces analysis 120
Macroeconomic indicators 129
Pharmaceuticals in The United States 131
Market Overview 131
Market Data 132
Market Segmentation 133
Market outlook 135
Five forces analysis 136
Macroeconomic indicators 146
Company Profiles 148
Leading Companies 148
Appendix 203
Methodology 203
About MarketLine 204

List of Tables
Table 1: G8 pharmaceuticals industry, revenue($bn), 2013-22
Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2013-17
Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2017-22
Table 4: Canada pharmaceuticals market value: $ billion, 2013-17
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2017
Table 6: Canada pharmaceuticals market share: % share, by value, 2017
Table 7: Canada pharmaceuticals market value forecast: $ billion, 2017-22
Table 8: Canada size of population (million), 2013-17
Table 9: Canada gdp (constant 2005 prices, $ billion), 2013-17
Table 10: Canada gdp (current prices, $ billion), 2013-17
Table 11: Canada inflation, 2013-17
Table 12: Canada consumer price index (absolute), 2013-17
Table 13: Canada exchange rate, 2013-17
Table 14: France pharmaceuticals market value: $ billion, 2013-17
Table 15: France pharmaceuticals market geography segmentation: $ billion, 2017
Table 16: France pharmaceuticals market share: % share, by value, 2017
Table 17: France pharmaceuticals market value forecast: $ billion, 2017-22
Table 18: France size of population (million), 2013-17
Table 19: France gdp (constant 2005 prices, $ billion), 2013-17
Table 20: France gdp (current prices, $ billion), 2013-17
Table 21: France inflation, 2013-17
Table 22: France consumer price index (absolute), 2013-17
Table 23: France exchange rate, 2013-17
Table 24: Germany pharmaceuticals market value: $ billion, 2013-17
Table 25: Germany pharmaceuticals market geography segmentation: $ billion, 2017
Table 26: Germany pharmaceuticals market share: % share, by value, 2017
Table 27: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Table 28: Germany size of population (million), 2013-17
Table 29: Germany gdp (constant 2005 prices, $ billion), 2013-17
Table 30: Germany gdp (current prices, $ billion), 2013-17
Table 31: Germany inflation, 2013-17
Table 32: Germany consumer price index (absolute), 2013-17
Table 33: Germany exchange rate, 2013-17
Table 34: Italy pharmaceuticals market value: $ billion, 2013-17
Table 35: Italy pharmaceuticals market geography segmentation: $ billion, 2017
Table 36: Italy pharmaceuticals market share: % share, by value, 2017
Table 37: Italy pharmaceuticals market value forecast: $ billion, 2017-22
Table 38: Italy size of population (million), 2013-17
Table 39: Italy gdp (constant 2005 prices, $ billion), 2013-17
Table 40: Italy gdp (current prices, $ billion), 2013-17
Table 41: Italy inflation, 2013-17
Table 42: Italy consumer price index (absolute), 2013-17
Table 43: Italy exchange rate, 2013-17
Table 44: Japan pharmaceuticals market value: $ billion, 2013-17
Table 45: Japan pharmaceuticals market geography segmentation: $ billion, 2017
Table 46: Japan pharmaceuticals market share: % share, by value, 2017
Table 47: Japan pharmaceuticals market value forecast: $ billion, 2017-22
Table 48: Japan size of population (million), 2013-17
Table 49: Japan gdp (constant 2005 prices, $ billion), 2013-17
Table 50: Japan gdp (current prices, $ billion), 2013-17
Table 51: Japan inflation, 2013-17
Table 52: Japan consumer price index (absolute), 2013-17
Table 53: Japan exchange rate, 2013-17
Table 54: Russia pharmaceuticals market value: $ billion, 2013-17
Table 55: Russia pharmaceuticals market geography segmentation: $ billion, 2017
Table 56: Russia pharmaceuticals market share: % share, by value, 2017
Table 57: Russia pharmaceuticals market value forecast: $ billion, 2017-22
Table 58: Russia size of population (million), 2013-17
Table 59: Russia gdp (constant 2005 prices, $ billion), 2013-17
Table 60: Russia gdp (current prices, $ billion), 2013-17

List of Figures
Figure 1: G8 pharmaceuticals industry, revenue($bn), 2013-22
Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2017
Figure 3: G8 pharmaceuticals industry, revenue by country ($bn), 2013-17
Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2017-22
Figure 5: Canada pharmaceuticals market value: $ billion, 2013-17
Figure 6: Canada pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 7: Canada pharmaceuticals market share: % share, by value, 2017
Figure 8: Canada pharmaceuticals market value forecast: $ billion, 2017-22
Figure 9: Forces driving competition in the pharmaceuticals market in Canada, 2017
Figure 10: Drivers of buyer power in the pharmaceuticals market in Canada, 2017
Figure 11: Drivers of supplier power in the pharmaceuticals market in Canada, 2017
Figure 12: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2017
Figure 13: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2017
Figure 14: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2017
Figure 15: France pharmaceuticals market value: $ billion, 2013-17
Figure 16: France pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 17: France pharmaceuticals market share: % share, by value, 2017
Figure 18: France pharmaceuticals market value forecast: $ billion, 2017-22
Figure 19: Forces driving competition in the pharmaceuticals market in France, 2017
Figure 20: Drivers of buyer power in the pharmaceuticals market in France, 2017
Figure 21: Drivers of supplier power in the pharmaceuticals market in France, 2017
Figure 22: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2017
Figure 23: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2017
Figure 24: Drivers of degree of rivalry in the pharmaceuticals market in France, 2017
Figure 25: Germany pharmaceuticals market value: $ billion, 2013-17
Figure 26: Germany pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 27: Germany pharmaceuticals market share: % share, by value, 2017
Figure 28: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Figure 29: Forces driving competition in the pharmaceuticals market in Germany, 2017
Figure 30: Drivers of buyer power in the pharmaceuticals market in Germany, 2017
Figure 31: Drivers of supplier power in the pharmaceuticals market in Germany, 2017
Figure 32: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2017
Figure 33: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2017
Figure 34: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2017
Figure 35: Italy pharmaceuticals market value: $ billion, 2013-17
Figure 36: Italy pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 37: Italy pharmaceuticals market share: % share, by value, 2017
Figure 38: Italy pharmaceuticals market value forecast: $ billion, 2017-22
Figure 39: Forces driving competition in the pharmaceuticals market in Italy, 2017
Figure 40: Drivers of buyer power in the pharmaceuticals market in Italy, 2017
Figure 41: Drivers of supplier power in the pharmaceuticals market in Italy, 2017
Figure 42: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2017
Figure 43: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2017
Figure 44: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2017
Figure 45: Japan pharmaceuticals market value: $ billion, 2013-17
Figure 46: Japan pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 47: Japan pharmaceuticals market share: % share, by value, 2017
Figure 48: Japan pharmaceuticals market value forecast: $ billion, 2017-22
Figure 49: Forces driving competition in the pharmaceuticals market in Japan, 2017
Figure 50: Drivers of buyer power in the pharmaceuticals market in Japan, 2017
Figure 51: Drivers of supplier power in the pharmaceuticals market in Japan, 2017
Figure 52: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2017
Figure 53: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2017
Figure 54: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2017
Figure 55: Russia pharmaceuticals market value: $ billion, 2013-17
Figure 56: Russia pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 57: Russia pharmaceuticals market share: % share, by value, 2017
Figure 58: Russia pharmaceuticals market value forecast: $ billion, 2017-22
Figure 59: Forces driving competition in the pharmaceuticals market in Russia, 2017
Figure 60: Drivers of buyer power in the pharmaceuticals market in Russia, 2017
Figure 61: Drivers of supplier power in the pharmaceuticals market in Russia, 2017
Figure 62: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *